Scheme 3 - Structures of compounds used in the present study.
From the following article
John W Giraldes, David L Akey, Jeffrey D Kittendorf, David H Sherman, Janet L Smith & Robert A Fecik
Nature Chemical Biology 2, 531 - 536 (2006) Published online: 10 September 2006
doi:10.1038/nchembio822

(a) Structures of the three candidate affinity labels. (b) Synthesis of triketide phosphonates Compound 11, Compound 12 and Compound 13. Reagents: a, CS2, KOH, H2O, 86%; b, n-BuLi, EtCOCl, 93%; c, EtCHO, TiCl4, NMP, (–)-sparteine, 98%; d, 2,6-lutidine, TESOTf, 95%; e, (PhO)2P(O)Me, LiHMDS, 90%; f, CSA, 87%; g, Zn(BH4)2, 83%; h, Me2C(OMe)2, p-TsOH, 98%; i, 2.5% aq. Na2CO3, 4%. Bn, benzyl; CSA, camphorsulfonic acid; HMDS, hexamethyldisilazide; NMP, N-methylpyrrolidone; Ph, phenyl; TES, triethylsilyl; Tf, trifluoromethanesulfonyl.
